Free Assessment

Guide

The 2027 Medicare fee schedule: what changes for retina and cataract practices.

By the Rekha Technologies team · Updated November 18, 2026. We update this guide when Medicare publishes changes.

In one sentence

Medicare will pay less for most eye care in 2027: the conversion factor falls 2.31 percent for clinicians outside advanced payment models, CMS estimates a further cut of about 3 percent for ophthalmology from changes to relative values, and an office visit billed on the same day as an eye injection now triggers a payment reduction.

Source: the CY 2027 Medicare Physician Fee Schedule final rule, published in the Federal Register on November 9, 2026 and effective January 1, 2027.

This guide covers what the 2027 rule means for practices that bill for retina and cataract surgeons: the overall cut, the new same-day rule that hits eye injections, cataract surgery, eye imaging, retina drugs, quality reporting and prior authorization. Every figure comes from CMS unless we say otherwise. Amounts are national, before the geographic adjustment for your area.

The headline: a lower conversion factor

Medicare pays for each service by multiplying its relative value units (RVUs) by a dollar amount called the conversion factor. For 2027 there are two:

  • $32.6286 for clinicians who are not qualifying participants in an advanced alternative payment model, down 2.31 percent from $33.4009. This is the one that applies unless your clinicians qualify through such a model.
  • $32.9548 for qualifying participants, down 1.83 percent from $33.5675.

The main reason is that a one-year 2.5 percent increase for 2026 has ended, and the small updates set in law for 2027 do not replace it.

On top of the conversion factor, CMS estimates that changes to relative values lower ophthalmology's Medicare payments by about 3 percent (3 percent for services in the office, 2 percent in facilities), almost all of it through practice expense. CMS shows this separately from the conversion factor change. One of the practice expense changes is the phase-out, over two years starting in 2027, of an old index used to share practice overhead among services. The 2.5 percent "efficiency adjustment" that cut procedure work values in 2026 is not repeated; CMS plans to apply it every three years.

The American Academy of Ophthalmology summarizes the result as a pay cut of between 1.8 and 2.3 percent, the two conversion factor changes, before the relative value changes for each service.

The same-day rule that matters most for retina

From January 1, 2027, when the same practitioner, or one of the same specialty in the same group, bills an office visit (codes 99202 to 99215) on the same day as a procedure with a 0-day global period, Medicare pays the higher-paid service in full and the others at 80 percent.

An intravitreal injection (67028) is a 0-day global procedure, and CMS discussed it by name. It asked for comments on eye injections, made no exception for them, and said it will consider the comments in future rulemaking. For scale, the national 2027 rates in the office are $108.65 for 67028, $92.01 for a 99213 visit and $131.17 for a 99214. With an injection and a 99213, the injection is the higher-paid service, so the visit is paid at 80 percent. With a 99214, the visit is higher, so the injection is paid at 80 percent.

Three details to know:

  • Only 0-day globals. CMS dropped 10-day and 90-day procedures from the final policy, so cataract surgery is not affected.
  • Only the listed visit codes. The final rule lists the office visit codes 99202 to 99215. It does not list the eye exam codes 92002 to 92014. Follow your Medicare contractor's instructions as they appear.
  • Do not reschedule care to avoid the cut. CMS says the policy does not stop same-day care, that scheduling patients on separate days to maximize payment is a problem, and that it will watch billing patterns.

Documentation matters more than ever. In May 2025 the HHS Office of Inspector General reviewed a sample of same-day visits billed with eye injections and found that the records for 22 of the 24 did not support billing the visit separately with modifier 25. It recommended that CMS review such claims and give more guidance.

Cataract surgery

  • Routine cataract surgery (66984), surgeon's fee in a facility: $442.12 in 2027, down from $462.60 in 2026, about 4 percent (CMS's own table of selected procedures).
  • Complex cataract surgery (66982): $602.65 in 2027, down from about $631 in 2026 (calculated from CMS's relative values for each year).
  • Laser treatment after cataract surgery (66821): $261.03 in a facility and $316.82 in the office in 2027, down from $275.22 and $335.35.

Commenters asked CMS to set an office-based (non-facility) rate for cataract surgery. CMS did not finalize one for 2027. Surgery center and hospital facility payments are set in a separate rule and are not covered here.

Eye imaging and exams

  • Retinal OCT (92134): $31.00 for the global service in the office in 2027, down from about $33; the physician's interpretation alone (modifier 26) is $16.97, down from about $17.70 (calculated from CMS's relative values).
  • Eye exams in the office: 92012 falls from $90.52 to $85.49, and 92014 from $127.26 to $120.40 (CMS's table).

Retina drugs

The 2027 rule does not change how Medicare Part B pays for retina drugs. Its drug provisions concern refunds that drug makers owe for discarded drug and inflation rebates. For your claims, keep reporting discarded drug from single-dose vials with the JW modifier, and use JZ when nothing was discarded.

Medicare Advantage plans may use step therapy for Part B drugs, but only for new starts, and they must look back at least 365 days (42 CFR § 422.136). The federal prior authorization deadlines for these plans that began in 2026 (72 hours for urgent and 7 calendar days for standard requests) do not cover drugs. CMS proposed in April 2026 to bring drugs under similar rules; that is a proposal, not a requirement.

Quality reporting (MIPS)

The MIPS performance threshold stays at 75 points for the 2027 performance year, which sets payment adjustments in 2029. CMS also finalized that from the 2031 performance year, clinicians who are not in a MIPS alternative payment model must report through a MIPS Value Pathway (MVP). There is time, but it pays to choose an MVP that fits your practice early. The new Ambulatory Specialty Model starting in 2027 covers heart failure and low back pain, not eye care.

Prior authorization in traditional Medicare

Medicare's WISeR model uses prior authorization for selected services in Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington from 2026 through 2031. Its published list of services does not include eye care.

What to do now

  • Load the 2027 Medicare rates for your locality into your billing system before January claims go out.
  • Check payer contracts that pay a percentage of Medicare rates; they may follow the cut automatically.
  • List your top codes (for example 66984, 66982, 67028, 92134 and your visit codes), multiply your volumes by the 2027 rates, and see the effect on revenue.
  • Review how same-day visits with injections are documented, so the record shows why the visit was significant and separately identifiable.
  • Update drug rates every quarter from Medicare's average sales price files, and keep the JW and JZ modifiers correct.
  • Confirm your 2027 MIPS reporting plan.
  • Watch for corrections: CMS sometimes corrects a final rule, and Congress can still change the conversion factor by law.

Rekha Technologies bills for retina and cataract surgeons' practices, not surgery centers. Our ophthalmology billing team bills injections and the drugs together, records drug units and unused amounts the way payers require, requests prior authorizations and follows step-therapy rules. Our coders are CPC-certified and experienced in eye care.

This guide is general information, not legal advice.

Sources

Quick answers

Questions about Medicare changes for eye care in 2027.

What is the 2027 Medicare conversion factor?

$32.6286 for clinicians who are not qualifying participants in an advanced alternative payment model, down 2.31 percent from $33.4009 in 2026, and $32.9548 for qualifying participants, down 1.83 percent. CMS finalized both in the CY 2027 Physician Fee Schedule final rule, published November 9, 2026 and effective January 1, 2027.

How much will Medicare pay for cataract surgery (66984) in 2027?

CMS's national figure for the surgeon's fee in a facility is $442.12 in 2027, down from $462.60 in 2026, about 4 percent. The amount for your practice differs with the geographic adjustment for your area.

Does the 2027 same-day payment reduction apply to eye injections?

Yes, when the visit is coded 99202 to 99215. If an office visit and a 0-day global procedure such as an intravitreal injection (67028) are billed on the same day by the same practitioner, or the same specialty in the group, Medicare pays the higher-paid service in full and the other at 80 percent. CMS made no exception for eye injections.

Does the 2027 same-day payment reduction apply to cataract surgery?

No. The reduction applies only to procedures with a 0-day global period. Cataract surgery has a 90-day global period, so it is not affected.

Does the 2027 rule change Medicare payment for retina drugs?

The 2027 physician fee schedule rule does not change how Part B pays for retina drugs. Its drug provisions concern refunds from drug makers for discarded drug and inflation rebates. Keep billing drug units correctly, with the JW modifier for discarded drug and JZ when none was discarded.

When do the 2027 Medicare payment changes take effect?

For services on or after January 1, 2027. CMS can publish corrections to a final rule, and Congress can change the conversion factor by law, so check for updates in December and January. We update this guide when Medicare publishes changes.

Does the 2027 Medicare rule add prior authorization for eye care?

Not in traditional Medicare. Medicare's WISeR prior authorization model, running in six states since 2026, does not list eye services. Medicare Advantage plans set their own rules and may require approval or step therapy for retina drugs, within federal limits.

Getting your eye care billing ready for 2027?

Tell us how your retina or cataract billing runs today, on a free 30-minute call. You get a quote for your practice.

Book a free 30-minute assessment
Book a free 30-minute assessment